Views: 0 Author: Site Editor Publish Time: 2026-09-07 Origin: Site
LUMBAR FUSION SUPPLIER GUIDE | Last reviewed: September 2026
A procurement-focused comparison of manufacturers that support lumbar fusion through interbody cages, posterior fixation, access systems, instruments, enabling technology, and market-specific distributor services.
The leading lumbar fusion implant manufacturers in 2026 include Medtronic, Globus Medical, DePuy Synthes, Stryker, ATEC, Orthofix, Highridge Medical, Spineart, ulrich medical, Sanyou Medical, and XC Medico. The best supplier is not simply the company with the largest catalog. Buyers should match each manufacturer’s confirmed TLIF, PLIF, ALIF, lateral or oblique coverage with posterior fixation, access and disc-preparation instruments, regulatory status, training, inventory, and local service. Global platform companies generally lead in integrated enabling technology; specialist and OEM-oriented manufacturers may offer more flexible territory, configuration, packaging, and commercial support. Product availability and indications must always be verified for the intended market.
This guide addresses a narrower and more commercial question than our Top Spine Implant Manufacturers in 2026 overview: which manufacturers can support a usable lumbar fusion portfolio across the approaches a distributor or hospital actually intends to offer? A company can be important in spine without having a balanced lumbar interbody business. Conversely, a focused lumbar supplier may be highly relevant to an importer even if it does not compete across cervical motion preservation, deformity, trauma, biologics, navigation, and every other spine segment.
For that reason, this list evaluates procedure coverage and operational completeness rather than revenue alone. It considers static and expandable lumbar cages, posterior pedicle screw fixation, anterior or lateral fixation where applicable, matched instruments, access systems, procedural integration, and distributor support. Buyers may describe the same search in broad terms such as lumbar spine implant manufacturers, lumbar fusion companies, lumbar fusion implant suppliers, interbody fusion manufacturers, or spinal fusion implant manufacturers; this guide applies one consistent procurement test to all of them. It is designed for commercial investigation by spine distributors, importers, private-label buyers, and hospital procurement teams. It is not a recommendation for an individual patient, a clinical ranking, or a claim that one implant design produces superior outcomes.
Names and ownership matter in 2026. Zimmer Biomet is not listed as a current spine manufacturer because its spine and dental businesses were separated into ZimVie in 2022; the spine assets were then sold and became Highridge Medical in 2024. Highridge is therefore evaluated as the current operating company. Globus Medical is assessed as the combined company following its merger with NuVasive. These corrections help purchasers avoid sending requests for quotation to a legacy corporate identity.
Last reviewed: September 7, 2026. We reviewed current manufacturer websites, procedure and product pages, official news releases, instructions for use where available, and FDA establishment or clearance records when they clarified corporate or regulatory status. The comparison records a capability as Confirmed only when a current first-party source clearly maps a product or platform to the relevant lumbar procedure. Verify by market means the company presents a relevant system, but availability, indication, brand name, or regulatory status may differ by country. Not confirmed means our review did not find adequate current public evidence; it does not prove that the manufacturer lacks the capability.
The order is editorial, not a clinical performance league table. Large global portfolios appear first because their procedural breadth and enabling technology are important to many buyers. Specialist and China-based manufacturers are then considered for focused portfolios, export access, or OEM relevance. Inclusion does not constitute endorsement, and no company paid for placement.
We checked whether current materials explicitly support TLIF, PLIF, ALIF, and a lateral pathway. This is the practical difference between comparing generic companies and comparing TLIF implant manufacturers, PLIF implant manufacturers, ALIF implant manufacturers, and OLIF implant manufacturers. Because manufacturers use LLIF, OLIF, ATP, DLIF, XLIF, PTP, or proprietary names differently, the table does not treat all lateral corridors as interchangeable. A distributor should confirm the exact surgical approach and level-specific indication.
We looked for approach-specific footprints, lordotic options, static or expandable designs, material choices, integrated fixation, graft delivery, and usable size breadth. This separates full-system suppliers from narrower lumbar interbody cage manufacturers or expandable lumbar cage manufacturers. We did not score a porous surface, PEEK, titanium, or expandable mechanism as inherently superior; these features must be interpreted with labeling, surgeon preference, patient anatomy, and supporting evidence.
A cage-only offer is not a complete lumbar fusion platform. We checked whether lumbar pedicle screw manufacturers could provide open or MIS screws, rods, reduction options, pelvic extensions where relevant, and compatibility with the manufacturer’s posterior lumbar fixation systems and enabling technology.
Trials, inserters, disc-preparation tools, retractors, access instruments, and tray architecture determine whether a catalog can become a repeatable hospital program. We gave greater relevance to manufacturers that publicly connect implants with matched lumbar fusion instrumentation.
Integrated platforms may combine positioning, access, neuromonitoring, imaging, navigation, robotics, fixation, interbody devices, biologics, and workflow software. This can simplify a strategic account, but it can also increase capital requirements and dependence on one vendor.
Regulatory clearance is market- and indication-specific. We therefore reviewed public status without implying global authorization. For importers, we also considered whether public materials identify international operations, distributor contact, sterile supply, training, OEM/ODM, packaging, or catalog support. These commercial services still require direct verification and documented quality agreements.
The table is a sourcing map, not a substitute for current labeling. “Lateral” may refer to LLIF, OLIF, ATP, PTP, or another named corridor.
| Manufacturer | TLIF | PLIF | ALIF | Lateral / oblique | Posterior fixation | Best procurement fit |
|---|---|---|---|---|---|---|
| Medtronic | Confirmed | Confirmed | Confirmed | Confirmed (OLIF) | Confirmed | Large integrated hospital platforms |
| Globus Medical | Confirmed | Confirmed | Confirmed | Confirmed (LLIF) | Confirmed | Broad implant plus enabling-technology programs |
| DePuy Synthes | Confirmed | Confirmed | Confirmed | Confirmed (LLIF) | Confirmed | Enterprise accounts and MIS-TLIF integration |
| Stryker | Confirmed | Confirmed | Confirmed | Confirmed (LLIF) | Confirmed | 3D-printed cages with navigation integration |
| ATEC | Confirmed | Confirmed | Confirmed | Confirmed (PTP/LTP) | Confirmed | Procedure-specific lateral and single-position programs |
| Orthofix | Confirmed | Confirmed | Confirmed | Confirmed (LLIF/ATP) | Confirmed | Implants, biologics, and bone-growth ecosystem |
| Highridge Medical | Confirmed | Confirmed | Confirmed | Confirmed (LLIF) | Confirmed | Legacy portfolio continuity plus expandable systems |
| Spineart | Confirmed | Confirmed | Confirmed | Confirmed (LLIF) | Confirmed | Focused, sterile-packed spine portfolio |
| ulrich medical | Confirmed | Confirmed | Confirmed | Confirmed (DLIF) | Confirmed | European specialist and sterile implant programs |
| Sanyou Medical | Confirmed | Verify by market | Confirmed | Confirmed (CLIF) | Confirmed | China-market scale and procedure innovation |
| XC Medico | Confirmed | Confirmed | Confirmed | Confirmed (OLIF) | Confirmed | Distributor and qualified OEM/ODM projects |
Headquarters: Dublin, Ireland, with major spine operations in the United States.
Key lumbar products: Catalyft PL/PL40 expandable posterior interbodies; Adaptix and Capstone posterior cages; Anteralign, Clydesdale, Pivox, Divergence-L, Perimeter, Sovereign, and Titan Endoskeleton anterior or oblique/lateral systems; CD Horizon Solera and Solera Voyager posterior fixation; OLIF access and disc-preparation instruments; Infuse Bone Graft.
Procedure coverage: TLIF, PLIF, ALIF, and Medtronic’s OLIF25/OLIF51 pathways are publicly documented.
Posterior fixation: Confirmed through Solera and Solera Voyager platforms.
Current status or regulatory: In February 2026, Medtronic announced FDA PMA approval expanding Infuse Bone Graft to indicated one- and two-level TLIF procedures from L2-S1 with specified PEEK or titanium cages. A September 2025 field correction for Catalyft PL/PL40 added labeling and technique information concerning potential loss of lordosis; Medtronic stated the system met specifications and could continue to be used. Buyers should review the latest IFU and local notices.
Distributor relevance: Strongest for health systems seeking a broad, integrated implant, biologics, navigation, and robotics ecosystem; access and capital requirements may be substantial.
Why it stands out: Medtronic offers one of the clearest end-to-end procedure maps, especially for OLIF. Its public OLIF pages connect access, disc preparation, interbody systems, biologics, posterior fixation, and navigation. That integration is valuable when a hospital wants one strategic platform rather than separate cage, screw, and enabling-technology vendors. The purchasing team should still distinguish a system’s technical compatibility from its approved indication and confirm country-specific availability.
Headquarters: Audubon, Pennsylvania, United States.
Key lumbar products: HEDRON A, IA, L, P, and T 3D-printed interbodies; Modulus ALIF; RISE, RISE IntraLIF, MLX and other expandable posterior systems; InterContinental lateral plate-spacer; CREO thoracolumbar stabilization; MAS TLIF/PLIF and MaXcess access; Excelsius enabling technology.
Procedure coverage: The HEDRON platform explicitly spans ALIF, LLIF, PLIF, and TLIF; other products add expandable and approach-specific options.
Posterior fixation: Confirmed through CREO systems and associated instruments.
Current status or regulatory: Globus operates as the combined Globus Medical/NuVasive company. Product availability and labeling remain market-specific, and the company’s own pages instruct buyers to verify local use.
Distributor relevance: Particularly relevant to hospitals prioritizing breadth, expandable cage choice, lateral access, and robotic or navigated workflows.
Why it stands out: Globus provides an unusually broad choice of static, expandable, integrated, and approach-specific devices. For a procurement team, that breadth can support multiple surgeon preferences inside one account. It also makes SKU governance important: distributors should define which footprints, lordosis ranges, inserters, graft-delivery components, and fixation modules will be stocked instead of treating the full catalog as one practical set.
Headquarters: Raynham, Massachusetts, United States, within Johnson & Johnson MedTech.
Key lumbar products: CONDUIT 3D-printed porous titanium cages for TLIF, PLIF, ALIF, and lateral fusion; CONCORDE lumbar systems; X-PAC expandable TLIF and LLIF systems; TriALTIS posterior fixation; TELIGEN visualization and access; UNLEASH implant bundles; VELYS enabling technology.
Procedure coverage: Confirmed across TLIF, PLIF, ALIF, and LLIF.
Posterior fixation: Confirmed through TriALTIS and legacy compatible platforms.
Current status or regulatory: DePuy Synthes acquired Expanding Innovations in July 2026, adding the commercial X-PAC TLIF, X-PAC LLIF, and N-GAGE lumbar plate systems and a stated pipeline that includes future ALIF expansion. TELIGEN received FDA 510(k) clearance in 2022 for an integrated MIS-TLIF workflow.
Distributor relevance: Strong for enterprise hospital systems that value a broad orthopedic relationship, procedural bundles, and digital integration.
Why it stands out: The July 2026 Expanding Innovations acquisition is material because it changes DePuy Synthes’ expandable lumbar position now, not merely its future roadmap. Procurement documents should separate commercial products from pipeline statements: X-PAC TLIF and LLIF were identified as commercial, while next-generation cages and ALIF expansion were described as planned. That distinction prevents a distributor from promising a product that is not yet released or authorized.
Headquarters: Portage, Michigan, United States.
Key lumbar products: Tritanium TL and PL posterior lumbar cages; Monterey AL standalone ALIF; Cascadia posterior and lateral cages; Everest MI, Xia, Serrato, ES2 and related pedicle fixation offered through the current Stryker/VB Spine relationship; Q Guidance and Spine Guidance technology.
Procedure coverage: Current public portfolios confirm posterior lumbar, ALIF, and lateral systems. Specific TLIF/PLIF mapping should be checked against each implant’s IFU.
Posterior fixation: Confirmed through multiple pedicle screw families and their current strategic integration.
Current status or regulatory: Stryker’s current spine page explains that specified VB Spine implants are compatible with selected Stryker guidance and power technologies. The Tritanium TL cage has FDA 510(k) clearance; availability still varies by market.
Distributor relevance: Fits hospitals interested in 3D-printed interbody devices, navigation, power, and a wider Stryker capital-equipment relationship.
Why it stands out: Stryker’s portfolio must be sourced with attention to the current commercial relationship. A buyer should identify which entity supplies the implant, instrument set, disposable, software, and service contract in the target region. This is more useful than relying on older brochures that simply label all products “Stryker Spine.”
Headquarters: Carlsbad, California, United States.
Key lumbar products: IdentiTi, Calibrate, Novel, and Transcend interbodies; IdentiTi ALIF Standalone; Calibrate LTX expandable lateral system; Invictus and Arsenal fixation; Sigma TLIF, ALIF, and lateral access; PTP and LTP positioning; SafeOp and Valence enabling technologies.
Procedure coverage: ATEC publishes integrated offerings for TLIF, PLIF, ALIF, PTP, and LTP pathways.
Posterior fixation: Confirmed through Invictus, Arsenal, and other ATEC systems.
Current status or regulatory: Recent public IFUs document IdentiTi ALIF, Transcend, Calibrate LTX, and Invictus indications and required supplemental fixation. Availability must be verified by market.
Distributor relevance: Most relevant where a hospital wants procedure-specific access, positioning, neural information, implants, and fixation rather than a cage-only purchase.
Why it stands out: ATEC organizes its offer around surgical approaches. Its PTP pathway, for example, publicly connects patient positioning, lateral access, neural monitoring, interbody implants, plates, biologics, and fixation. This makes evaluation easier at the workflow level. It also means the buyer should model total procedural cost and training, not just implant price.
Headquarters: Lewisville, Texas, United States.
Key lumbar products: FORZA PTC and FORZA XP posterior spacers; Reef A and Meridian anterior systems; WaveForm and Lattus interbodies; Regatta lateral plate; Firebird and Mariner posterior fixation families; ATP and lateral disc-preparation instruments; biologics and bone-growth therapies.
Procedure coverage: Orthofix’s current lumbar interbody page explicitly maps ALIF, LLIF, PLIF, and TLIF solutions.
Posterior fixation: Confirmed through its posterior thoracolumbar portfolio.
Current status or regulatory: The company presents current market-specific product pages and IFUs. FORZA XP is identified for PLIF and TLIF, while FORZA PTC includes posterior and oblique applications; exact claims require local labeling review.
Distributor relevance: Useful for accounts seeking implants plus biologics or bone-growth therapy, subject to local distribution structure and regulatory access.
Why it stands out: Orthofix links lumbar implants to complementary fusion technologies. That can support a broader value proposition, but it also increases compliance complexity: biologics, stimulation devices, implants, and instruments may have different registrations, reimbursement pathways, storage requirements, and contracts.
Headquarters: Westminster, Colorado, United States.
Key lumbar products: FlareHawk expandable TLIF/PLIF; TrellOss-TC and TS posterior cages; TrellOss-A SA, Durango, ROI-A and Toro-L anterior systems; TrellOss-L MPF and Timberline lateral systems; Vital, Vital MIS, Vitality, Polaris, PathFinder NXT, and LineSider fixation.
Procedure coverage: The current thoracolumbar directory explicitly organizes ALIF, TLIF/PLIF, lateral, MIS fixation, and posterior deformity solutions.
Posterior fixation: Confirmed across open and MIS systems.
Current status or regulatory: H.I.G. Capital formed Highridge from the former ZimVie spine business in 2024. In September 2025, Highridge acquired FlareHawk, Toro, and LineSider assets. FDA’s 2026 establishment record lists Highridge as active and includes legacy trade names such as Zimmer Biomet Spine and ZimVie.
Distributor relevance: Important for continuity of former Zimmer Biomet/ZimVie spine lines and for accounts evaluating newer expandable systems.
Why it stands out: Highridge resolves the largest naming trap in this comparison. Buyers with older specifications may still see Zimmer Biomet Spine or ZimVie on historical documents. Current tenders should identify Highridge, confirm the legal manufacturer and local registration for each catalog number, and avoid assuming that every legacy product transferred unchanged in every jurisdiction.
Headquarters: Geneva, Switzerland.
Key lumbar products: JULIET Ti posterior and lateral cages; SCARLET AL-T secured anterior cage; PERLA TL and PERLA TL MIS thoracolumbar fixation; CURE LP lumbar plate; procedure-specific instruments.
Procedure coverage: Spineart’s current interbody portfolio maps posterior cages to PO, OL, and TL configurations, plus LLIF and ALIF products. Buyers should verify the exact mapping of each posterior model to TLIF or PLIF in local labeling.
Posterior fixation: Confirmed through PERLA TL and PERLA TL MIS.
Current status or regulatory: Current product pages emphasize sterile-packed, barcoded implants and note that availability depends on market. Clinical or preclinical claims should be read with the cited study design and IFU.
Distributor relevance: Attractive to focused spine distributors that value a compact specialist portfolio and sterile implant logistics.
Why it stands out: Spineart offers a coherent specialist identity: interbody fusion, posterior fixation, and sterile traceability are visible across the portfolio. For a distributor, this may reduce the gap between a broad multinational platform and a basic private-label catalog. Territory availability and direct-versus-distributor sales policy remain decisive.
Headquarters: Ulm, Germany.
Key lumbar products: pezo PEEK cage family for PLIF, TLIF, and ALIF; tezo titanium cages; Bone InGrowth 3D-printed cages for PLIF, TLIF, ALIF, and DLIF; uCentum thoracolumbosacral screw-rod system; uDesis bone graft material.
Procedure coverage: Confirmed for TLIF, PLIF, ALIF, and a direct lateral pathway; “OLIF” as a named pathway was not confirmed in the reviewed public range.
Posterior fixation: uCentum supports open and percutaneous applications and can integrate with specified navigation systems.
Current status or regulatory: Product pages state that all pezo cages are sterile and that country-specific availability must be considered for the Bone InGrowth family.
Distributor relevance: Relevant to European and international specialists looking for German-manufactured cage and fixation systems with sterile options.
Why it stands out: ulrich medical publishes practical details on approach families and shared instrumentation. The same pezo inserter concept supports PLIF and TLIF, which may reduce instrument complexity. Buyers should still validate tray count, replenishment, repair service, and whether the locally registered configuration matches the global website.
Headquarters: Shanghai, China.
Key lumbar products: Halis lumbar cage systems; Keystone lumbar fusion system; ALIF and CLIF procedural lines; ZELIF endoscopic-assisted percutaneous lumbar fusion; Zina and Lora MIS systems; Adena thoracolumbar posterior pedicle screw system; surface-modified PEEK cage development.
Procedure coverage: The current corporate site lists ALIF, CLIF, ZELIF, UBE, interbody fusion, MIS, and thoracolumbar fixation. A distinct current PLIF product mapping was not sufficiently explicit in the English public pages reviewed, so PLIF should be verified by market.
Posterior fixation: Confirmed through Adena, Zina, Lora, and related thoracolumbar/MIS lines.
Current status or regulatory: Sanyou is listed on China’s STAR Market and states that it controls France-based Implanet. Its site documents a broad orthopedic product matrix and international expansion; individual registrations require country review.
Distributor relevance: Relevant to buyers seeking a large Chinese spine innovator, especially in Asia and selected international markets.
Why it stands out: Sanyou is more than a commodity cage producer. Its public portfolio is organized around named procedural concepts, including CLIF and ZELIF, with access and fixation components. For importers, the important task is to translate those proprietary procedures into the target market’s regulatory terminology, training expectations, and surgeon demand.
Headquarters: Changzhou, Jiangsu, China.
Key lumbar products: TLIF and PLIF PEEK cages and instruments; titanium TLIF cage; ALIF cage and ATLPS plate; standalone ALIF cage; OLIF system; expandable PVE cage for MIS-TLIF/UBE; 5.5 mm and 6.0 mm open and MIS pedicle screw systems; matched instrument sets.
Procedure coverage: Current pages confirm TLIF/MIS-TLIF, PLIF, ALIF, and OLIF product or solution coverage.
Posterior fixation: Confirmed through open, reduction, MIS, and cement-augmented pedicle screw options.
Current status or regulatory: XC Medico states ISO 13485 certification and provides market-dependent product documentation. Certifications, registrations, models, and claims must be verified for the buyer’s destination and intended use before contracting.
Distributor relevance: Focused on distributors, hospitals, and qualified OEM/ODM projects requiring coordinated implants, instruments, catalogs, packaging, and configuration discussions.
Why it stands out: XC Medico’s role in this list is not to claim parity with the capital-technology scale of the global majors. Its relevance is a different procurement model: a buyer can discuss a coordinated spine implant portfolio, matched instruments, smaller commercial configurations, and OEM/ODM services. Prospective partners should audit the factory and quality system, review current certificates and technical files, test instruments, confirm sterilization and packaging responsibilities, and obtain written regulatory evidence for every destination market.
Buyers can review XC Medico’s individual TLIF/MIS-TLIF solution, PLIF solution, ALIF solution, and OLIF system before requesting a configuration.
Weigao Group’s official site confirms a spine business, and FDA’s establishment database showed Shandong Weigao Orthopaedic listings for lumbar intervertebral fusion devices in 2026. However, the current English corporate page did not provide enough product-level, procedure-specific detail for us to map TLIF, PLIF, ALIF, lateral fusion, instruments, and fixation with the same confidence used for the ranked companies. Weigao may still be a valid supplier; it should be assessed through current catalogs, IFUs, certificates, and market registrations rather than included to fill a quota.
TLIF uses a unilateral posterior or posterolateral corridor. A practical TLIF portfolio usually includes straight, banana-shaped, steerable, articulating, or expandable cages; trials; disc shavers and curettes; inserters; graft-delivery tools; and open or percutaneous pedicle screw fixation. The cage must be evaluated with its permitted graft materials and supplemental fixation. For product-level context, see the TLIF and PLIF cage manufacturer evaluation guide.
PLIF uses a bilateral posterior route more commonly associated with two smaller cages, although implant and technique options vary. Procurement should verify whether a posterior cage is actually labeled and instrumented for PLIF, not assume that every “posterior lumbar” implant supports both PLIF and TLIF. A complete set needs bilateral preparation and insertion capability, compatible graft packing, and posterior stabilization. XC Medico’s PLIF cage instrument set illustrates the need to evaluate implants and tools together.
ALIF cages generally use larger footprints and may be offered with separate anterior plates, integrated screws or anchors, or required posterior supplemental fixation. Buyers should review approach level, footprint, lordosis, fixation, locking mechanism, vascular-access workflow, retractor and disc-preparation sets, and whether access instruments come from the implant company or a separate provider. Integrated fixation does not automatically mean a device is “standalone” for every indication.
OLIF, LLIF, ATP, DLIF, XLIF, PTP, and similar names describe different trajectories or proprietary workflows. They should not be collapsed into one procurement checkbox. The cage footprint and inserter angle, retractor, neuromonitoring needs, level access, plate options, patient positioning, and posterior fixation sequence can differ. Ask the supplier to map every component to the intended approach and level.
Posterior lumbar fixation may include monoaxial, polyaxial, reduction, cannulated, fenestrated, cortical-trajectory, iliac, or other screw options; rods; set screws; connectors; reduction instruments; towers; and navigation-ready tools. The commercially relevant question is whether the selected screw family covers the cases and workflow of the target hospital. Review our pedicle screw manufacturer evaluation guide and MIS pedicle screw system page for a more detailed checklist.
Expandable cages may reduce insertion profile and allow in-situ height or lordosis adjustment, but designs differ in direction of expansion, footprint, locking, graft delivery, material, and labeling. Expansion should not be treated as proof of better outcomes. Procurement should request mechanical testing summaries, deployment limits, imaging compatibility, surgeon training, complaint history, field safety notices, and the latest IFU. Static and expandable options can coexist in a balanced portfolio.
| Requirement | TLIF | PLIF | ALIF | OLIF / oblique |
|---|---|---|---|---|
| Typical access | Unilateral posterior/transforaminal | Bilateral posterior | Anterior retroperitoneal | Anterolateral/oblique retroperitoneal |
| Cage priorities | Controlled insertion, rotation or articulation, graft access | Matched bilateral sizing and insertion | Large footprint, lordosis range, integrated or separate fixation | Long footprint, trajectory-specific inserter, plate option |
| Access instruments | Tubular or open retractor; posterior disc prep | Posterior retraction and bilateral disc prep | Anterior retractor and vessel-aware workflow | Approach-specific retractor, dilation, optional neuromonitoring |
| Fixation question | Usually posterior pedicle fixation | Usually posterior pedicle fixation | Integrated, anterior plate, posterior, or combination per labeling | Lateral plate and/or posterior fixation per labeling |
| Key procurement risk | Cage and inserter do not match surgeon trajectory | Insufficient paired inventory or instruments | Assuming “integrated” equals universally standalone | Treating different lateral approaches as equivalent |
A complete system is not a marketing image containing a cage and two screws. It is a documented procedure configuration that a trained surgical team can order, prepare, implant, replenish, and support consistently.
Before approving a system, build a procedure bill of materials for each target approach. Then simulate a case: cage selection, preparation, insertion, fixation, backup sizes, damaged instrument replacement, postoperative traceability, and complaint escalation. This exposes gaps that a catalog comparison misses.
Global platform brands usually provide deeper surgeon education, direct clinical support, established regulatory footprints, enabling technology, broad fixation, biologics, and large installed bases. Their advantages matter for complex tertiary accounts. Trade-offs may include higher acquisition cost, capital commitments, restricted territories, less packaging flexibility, and dependence on proprietary workflows.
OEM-oriented lumbar fusion manufacturers may offer lower entry barriers, flexible configuration, localized branding, coordinated instrument sourcing, and responsive portfolio building. These benefits are commercial, not automatic proof of quality or regulatory readiness. The buyer must perform more diligence on design ownership, supplier controls, process validation, sterilization, packaging, biocompatibility, mechanical testing, post-market surveillance, change notification, and the boundary between legal manufacturer and contract manufacturer.
The right choice can be a hybrid. A distributor may represent a premium integrated platform for high-volume centers while developing a carefully audited value portfolio for price-sensitive hospitals. The two lines need clear positioning so that training, claims, service expectations, and inventory do not become confused.
For buyers comparing Chinese and U.S. supply models, the China vs U.S. spine manufacturer evaluation guide provides a complementary framework. The interbody fusion cage category can also help translate the procedure matrix into a product shortlist.
Based on current public portfolio breadth, the leading manufacturers reviewed here are Medtronic, Globus Medical, DePuy Synthes, Stryker, ATEC, Orthofix, Highridge Medical, Spineart, ulrich medical, Sanyou Medical, and XC Medico. “Leading” depends on the buyer’s market, procedures, regulatory needs, service model, and budget; the list is not a clinical performance ranking.
A distributor should look for approach-specific cages, open or MIS posterior fixation, matched trials and inserters, complete disc-preparation and graft-delivery instruments, access systems where needed, and documented compatibility. The supplier should also provide current regulatory files, sterile and reusable-instrument logistics, training, replenishment, complaint handling, change notification, and territory terms. Every claim and model must be verified for the target market.
Current first-party materials confirm broad four-approach coverage for Medtronic, Globus Medical, DePuy Synthes, Stryker, ATEC, Orthofix, Highridge Medical, Spineart, and ulrich medical, although their lateral terminology differs. XC Medico publishes TLIF, PLIF, ALIF, and OLIF pages. Exact indications, models, and market availability must be checked; a global website is not local authorization.
Not categorically. Expandable cages may provide a smaller insertion profile and in-situ adjustment, while static cages can offer simpler mechanics and different footprint or cost options. Outcomes depend on indication, design, endplate preparation, positioning, bone quality, fixation, and surgical technique. Compare the specific device’s labeling, mechanical data, clinical evidence, risks, field notices, and training requirements.
No assumption of interchangeability is safe. Some posterior lumbar cage systems are labeled and instrumented for both approaches, while others have TLIF- or PLIF-specific geometry, insertion, quantities, or indications. Confirm the exact catalog number, IFU, trials, inserter, graft tools, supplemental fixation, and local registration before quoting or using a device.
Not always. Integrated screws, anchors, or plates provide fixation features, but whether a device may be used without supplemental posterior fixation depends on its design, indication, level, patient factors, and market-specific labeling. Procurement teams should avoid using “integrated” and “standalone” as synonyms unless the current IFU explicitly supports the intended configuration.
Zimmer Biomet separated its spine and dental businesses into ZimVie in 2022. H.I.G. Capital purchased the spine business in 2024 and formed Highridge Medical. Highridge is therefore the current company evaluated for the relevant legacy and expanded spine portfolio. Buyers should still check the legal manufacturer shown on each product’s current label and registration.
DePuy Synthes announced the acquisition of Expanding Innovations on July 16, 2026. The acquired commercial portfolio includes X-PAC expandable TLIF and LLIF cages and the N-GAGE lumbar plate. The announcement also described future portfolio expansion, including ALIF. Buyers should distinguish already commercial products from planned next-generation products.
Medtronic announced FDA PMA approval for Infuse Bone Graft in specified one- and two-level TLIF procedures from L2-S1 with permitted PEEK or titanium cages. It was a material indication expansion. It does not make Infuse universally approved for every cage, level, graft configuration, procedure, or country; users must follow the complete current labeling.
Start with a product and regulatory gap analysis, then audit design and manufacturing controls, traceability, biocompatibility, mechanical testing, sterilization, packaging, shelf life, labeling, post-market surveillance, and change control. Define who owns the design, registration, trademark, and complaint obligations. Evaluate instruments in a realistic workflow and confirm written territory, training, replenishment, recall, and termination terms.
Primary sources were prioritized. The most time-sensitive updates were checked against official company newsrooms and FDA pages. Selected source set:
Update policy: Recheck ownership, product status, FDA or other regulatory actions, field safety notices, official procedure pages, and country availability before the next annual update. Any future ranking change should be based on documented portfolio changes, not marketing language alone.
This article is an independent B2B procurement reference based on public information available through September 7, 2026. Product names are trademarks of their respective owners. Inclusion does not imply endorsement, commercial relationship, global availability, or clinical superiority. Medical devices must be selected and used by qualified professionals according to current local authorization, labeling, instructions for use, patient needs, and institutional policy.
Send XC Medico your target procedures, required cage materials and sizes, posterior fixation preferences, instrument needs, destination market, annual forecast, and OEM/ODM requirements. Our team can help organize a product and documentation shortlist for technical and commercial review.
Contact